IDSA2026EN
Hepatitis B
Zusammenfassung
AASLD/IDSA Practice Guideline Update on Treatment of Chronic Hepatitis B You are using an outdated browser. Please upgrade your browser to improve your experience and security. Advertisement Skip to nav Skip to content View All Guidelines ARCHIVED AASLD/IDSA Practice Guideline Update on Treatment of Chronic Hepatitis B Download PDF Copy Link Published September 01, 2009 Update Status This guideline has been archived. For the most recent version, please visit here . Introduction An estimated 350
Kerninformationen
s, hepatic decompensation, and hepatocellular carcinoma (HCC) (12). Although most carriers will not develop hepatic complications from chronic hepatitis B, 15% to 40% will develop serious sequelae during their lifetime (13). The following guidelines are an update to previous AASLD guidelines and ref...
scussed in these guidelines (14). Back to top Table of Contents Update Status Introduction Citation × Copy Citation ×
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
WHO2024
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection
USPSTF2020
USPSTF: Hepatitis B Virus Infection: Screening (Grade B)
IDSA2009
AASLD: Hepatitis B (2009)
WHO2026
Consolidated guidance on hepatitis B and C prevention, testing, treatment, service delivery and monitoring: an implementation handbook for a public health approach
IDSA2020
SHEA: Healthcare Personnel Living with Hepatitis B, Hepatitis C, or HIV
IDSA2023
AASLD/IDSA: HCV Guidance
WHO2024
WHO Guidelines on Hepatitis B and C Testing
SIGN2013